Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.53 USD | +3.75% |
|
+6.80% | -33.94% |
07-16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
07-03 | Oppenheimer Raises Price Target on Pharvaris to $38 From $36, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.94% | 997M | |
+25.83% | 47.96B | |
+44.70% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Sector Update: Health Care Stocks Decline Premarket Monday